Peterson P, Gray P, Tolman K G
Clin Pharmacol Ther. 1976 Jan;19(1):63-7. doi: 10.1002/cpt197619163.
The effect of oral vitamin D3 therapy on calcium balance was compared in 18 institutionalized subjects with drug-induced osteomalacia and in 18 similar subjects without osteomalacia. The subjects with osteomalacia were receiving standard doses of phenytoin and phenobarbital. Diagnosis of osteomalacia was based on low serum calcium and phosphorus, elevated alkaline phosphatase, and appropriate roentgenographic bone changes. The study group achieved positive calcium balance at approximately 975 IU of vitamin D3 per day, while the control group achieved positive calcium balance at approximately 380 IU of vitamin D3 per day. The difference is highly significant (p less than 0.001). These data support previous observations that the osteomalacia of patients receiving anticonvulsant drugs is related to the drugs and that these patients require supplemental doses of vitamin D.
在18名患有药物性骨软化症的机构收容受试者和18名无骨软化症的类似受试者中,比较了口服维生素D3疗法对钙平衡的影响。患有骨软化症的受试者正在接受标准剂量的苯妥英和苯巴比妥。骨软化症的诊断基于低血清钙和磷、碱性磷酸酶升高以及适当的X线骨改变。研究组每天约975国际单位维生素D3时实现钙平衡为正,而对照组每天约380国际单位维生素D3时实现钙平衡为正。差异具有高度显著性(p小于0.001)。这些数据支持了先前的观察结果,即接受抗惊厥药物治疗的患者的骨软化症与药物有关,且这些患者需要补充维生素D剂量。